Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of BAFNA PHARMA. For more details, see the BAFNA PHARMA quarterly results and BAFNA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.0 |
No. of shares | m | 23.66 |
1 Week | % | 0.6 |
1 Month | % | 9.5 |
1 Year | % | 2.1 |
52 week H/L | Rs | 125.6/76.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BAFNA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 30 | 11 | 196 | 191 | 141 | |
Low | Rs | 9 | 5 | 9 | 115 | 79 | |
Sales per share (Unadj.) | Rs | 18.4 | 179.2 | 30.1 | 36.0 | 48.8 | |
Earnings per share (Unadj.) | Rs | -8.2 | -7.9 | 2.5 | 2.2 | 4.8 | |
Diluted earnings per share | Rs | -8.2 | -0.8 | 2.5 | 2.2 | 4.8 | |
Cash flow per share (Unadj.) | Rs | -6.7 | 5.8 | 4.4 | 4.5 | 7.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 8.1 | -17.9 | 24.0 | 26.2 | 31.0 | |
Adj. book value per share | Rs | 8.1 | -1.8 | 24.0 | 26.2 | 31.1 | |
Shares outstanding (eoy) | m | 23.66 | 2.37 | 23.66 | 23.66 | 23.66 | |
Price / Sales ratio | x | 1.1 | 0 | 3.4 | 4.2 | 2.3 | |
Avg P/E ratio | x | -2.4 | -1.0 | 41.7 | 69.3 | 22.9 | |
P/CF ratio (eoy) | x | -2.9 | 1.3 | 23.6 | 33.8 | 15.6 | |
Price / Book Value ratio | x | 2.4 | -0.4 | 4.3 | 5.8 | 3.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 462 | 18 | 2,428 | 3,616 | 2,596 | |
Total wages/salary | Rs m | 90 | 103 | 120 | 146 | 159 |
BAFNA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 436 | 425 | 712 | 851 | 1,154 | |
Other income | Rs m | 4 | 3 | 7 | 18 | 33 | |
Total revenues | Rs m | 440 | 427 | 720 | 869 | 1,186 | |
Gross profit | Rs m | -131 | 12 | 103 | 97 | 157 | |
Depreciation | Rs m | 35 | 33 | 45 | 55 | 53 | |
Interest | Rs m | 21 | 1 | 7 | 8 | 20 | |
Profit before tax | Rs m | -183 | -19 | 58 | 52 | 116 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 11 | 0 | 0 | 0 | 3 | |
Profit after tax | Rs m | -194 | -19 | 58 | 52 | 113 | |
Gross profit margin | % | -30.0 | 2.9 | 14.5 | 11.4 | 13.6 | |
Effective tax rate | % | -5.8 | 0 | 0 | 0 | 2.4 | |
Net profit margin | % | -44.4 | -4.4 | 8.2 | 6.1 | 9.8 |
BAFNA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 485 | 361 | 497 | 509 | 873 | |
Current liabilities | Rs m | 708 | 171 | 243 | 220 | 465 | |
Net working cap to sales | % | -51.2 | 44.7 | 35.6 | 33.9 | 35.4 | |
Current ratio | x | 0.7 | 2.1 | 2.0 | 2.3 | 1.9 | |
Inventory Days | Days | 284 | 0 | 0 | 2 | 2 | |
Debtors Days | Days | 2,078 | 519 | 490 | 634 | 1,302 | |
Net fixed assets | Rs m | 710 | 352 | 368 | 393 | 423 | |
Share capital | Rs m | 237 | 24 | 237 | 237 | 237 | |
"Free" reserves | Rs m | -46 | -66 | 331 | 383 | 498 | |
Net worth | Rs m | 191 | -42 | 568 | 620 | 735 | |
Long term debt | Rs m | 230 | 30 | 25 | 53 | 84 | |
Total assets | Rs m | 1,195 | 713 | 865 | 901 | 1,296 | |
Interest coverage | x | -7.6 | -18.6 | 8.9 | 7.6 | 6.7 | |
Debt to equity ratio | x | 1.2 | -0.7 | 0 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.4 | 0.6 | 0.8 | 0.9 | 0.9 | |
Return on assets | % | -14.4 | -2.5 | 7.6 | 6.7 | 10.3 | |
Return on equity | % | -101.6 | 44.4 | 10.3 | 8.4 | 15.4 | |
Return on capital | % | -38.4 | 146.1 | 11.1 | 8.9 | 16.7 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 5.0 | 5.5 | 5.9 | 3.7 | 7.9 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 22 | 24 | 42 | 32 | 91 | |
Fx inflow | Rs m | 260 | 250 | 347 | 548 | 885 | |
Fx outflow | Rs m | 22 | 24 | 42 | 32 | 91 | |
Net fx | Rs m | 239 | 226 | 305 | 516 | 794 |
BAFNA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -18 | -343 | -136 | 97 | 50 | |
From Investments | Rs m | 154 | 328 | -53 | -65 | -75 | |
From Financial Activity | Rs m | -138 | 73 | 123 | -48 | 102 | |
Net Cashflow | Rs m | -2 | 58 | -67 | -16 | 76 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Bafna Mahaveer Chand | COMP SEC: Jitendra Kumar Pal | YEAR OF INC: 1995 | BSE CODE: 532989 | FV (Rs): 10 | DIV YIELD (%): - |
Read: BAFNA PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BAFNA PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.